| Requirement of bic/microRNA-155 for normal immune function A Rodriguez, E Vigorito, S Clare, MV Warren, P Couttet, DR Soond, ... Science 316 (5824), 608-611, 2007 | 2390 | 2007 |
| Excessive production of interleukin 6/B cell stimulatory factor‐2 in rheumatoid arthritis T Hirano, T Matsuda, M Turner, N Miyasaka, G Buchan, B Tang, K Sato, ... European journal of immunology 18 (11), 1797-1802, 1988 | 1037 | 1988 |
| microRNA-155 regulates the generation of immunoglobulin class-switched plasma cells E Vigorito, KL Perks, C Abreu-Goodger, S Bunting, Z Xiang, S Kohlhaas, ... Immunity 27 (6), 847-859, 2007 | 996 | 2007 |
| Perinatal lethality and blocked B-cell development in mice lacking the tyrosine kinase Syk M Turner, P Joseph Mee, PS Costello, O Williams, AA Price, LP Duddy, ... Nature 378 (6554), 298-302, 1995 | 933 | 1995 |
| A critical role for Syk in signal transduction and phagocytosis mediated by Fcγ receptors on macrophages MT Crowley, PS Costello, CJ Fitzer-Attas, M Turner, F Meng, C Lowell, ... The Journal of experimental medicine 186 (7), 1027-1039, 1997 | 665 | 1997 |
| The Fc receptor γ‐chain and the tyrosine kinase Syk are essential for activation of mouse platelets by collagen A Poole, JM Gibbins, M Turner, MJ Van Vugt, JGJ Van de Winkel, T Saito, ... The EMBO journal, 1997 | 580 | 1997 |
| A crucial role for the p110δ subunit of phosphatidylinositol 3-kinase in B cell development and activation E Clayton, G Bardi, SE Bell, D Chantry, CP Downes, A Gray, ... The Journal of experimental medicine 196 (6), 753-763, 2002 | 576 | 2002 |
| Tyrosine kinase SYK: essential functions for immunoreceptor signalling M Turner, E Schweighoffer, F Colucci, JP Di Santo, VL Tybulewicz Immunology today 21 (3), 148-154, 2000 | 571 | 2000 |
| Inactivation of PI (3) K p110δ breaks regulatory T-cell-mediated immune tolerance to cancer K Ali, DR Soond, R Pineiro, T Hagemann, W Pearce, EL Lim, H Bouabe, ... Nature 510 (7505), 407-411, 2014 | 547 | 2014 |
| Defective antigen receptor-mediated proliferation of B and T cells in the absence of Vav A Tarakhovsky, M Turner, S Schaal, PJ Mee, LP Duddy, K Rajewsky, ... Nature 374 (6521), 467-470, 1995 | 479 | 1995 |
| Cutting edge: the Foxp3 target miR-155 contributes to the development of regulatory T cells S Kohlhaas, OA Garden, C Scudamore, M Turner, K Okkenhaug, ... The Journal of Immunology 182 (5), 2578-2582, 2009 | 477 | 2009 |
| Interleukin-1 and tumour necrosis factor mRNA expression in rheumatoid arthritis: prolonged production of IL-1 alpha. G Buchan, K Barrett, M Turner, D Chantry, RN Maini, M Feldmann Clinical and experimental immunology 73 (3), 449, 1988 | 462 | 1988 |
| Modulation of cytokine production by transforming growth factor-beta. D Chantry, M Turner, E Abney, M Feldmann Journal of immunology (Baltimore, Md.: 1950) 142 (12), 4295-4300, 1989 | 442 | 1989 |
| Expression of granulocyte‐macrophage colony‐stimulating factor in rheumatoid arthritis: regulation by tumor necrosis factor‐α C Haworth, FM Brennan, D Chantry, M Turner, RN Maini, M Feldmann European journal of immunology 21 (10), 2575-2579, 1991 | 427 | 1991 |
| VAV proteins as signal integrators for multi-subunit immune-recognition receptors M Turner, DD Billadeau Nature Reviews Immunology 2 (7), 476-486, 2002 | 400 | 2002 |
| Sequential activation of class IB and class IA PI3K is important for the primed respiratory burst of human but not murine neutrophils AM Condliffe, K Davidson, KE Anderson, CD Ellson, T Crabbe, ... Blood 106 (4), 1432-1440, 2005 | 388 | 2005 |
| Critical role for the tyrosine kinase Syk in signalling through the high affinity IgE receptor of mast cells. PS Costello, M Turner, AE Walters, CN Cunningham, PH Bauer, ... Oncogene 13 (12), 2595-2605, 1996 | 387 | 1996 |
| Tumour necrosis factor as an autocrine tumour growth factor for chronic B-cell malignancies FT Cordingley, AV Hoffbrand, HE Heslop, M Turner, A Bianchi, JE Reittie, ... The Lancet 331 (8592), 969-971, 1988 | 371 | 1988 |
| The microRNA miR-155 controls CD8+ T cell responses by regulating interferon signaling DT Gracias, E Stelekati, JL Hope, AC Boesteanu, TA Doering, J Norton, ... Nature immunology 14 (6), 593-602, 2013 | 349 | 2013 |
| A requirement for the Rho-family GTP exchange factor Vav in positive and negative selection of thymocytes M Turner, PJ Mee, AE Walters, ME Quinn, AL Mellor, R Zamoyska, ... Immunity 7 (4), 451-460, 1997 | 347 | 1997 |
Victor TybulewiczFrancis Crick InstituteVerified email at crick.ac.uk
